menu
Global Continuous Manufacturing Market Professional Survey Report by 2030
Continuous Manufacturing Market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis

Recentadvances in the manufacturing technologies have prompted pharmaceuticalcompanies to consider shifting from the traditional multi-step, batchmanufacturing processes to faster, and relatively more efficient continuousmanufacturing

RootsAnalysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 –2030.” 

Thereport features an extensive study of the current market landscape and futureopportunities for companies with capabilities in continuous manufacturing (bothinnovator companies with in-house expertise and contract manufacturers). Itfeatures an in-depth analysis, highlighting the capabilities of variousstakeholders engaged in this domain. In addition to other elements, the studyincludes:

·       A  detailedassessment of the overall landscape of companies with capabilities forcontinuous manufacturing

·       Elaborate profiles of some of the keycontract manufacturers active in the pharmaceutical and biopharmaceuticalcontinuous manufacturing market

·       An analysis of the various partnershipsrelated to continuous manufacturing, which have been established since 2013

·       An analysis of the expansions related tocontinuous manufacturing, which have been established since 2013

·       An estimate of the global, continuous manufacturingcapacity, based on the capacities of various industry stakeholders (asavailable on their respective company websites).

·       A study of the various grants that have beenawarded to research institutes engaged in projects related to continuousmanufacturing, between 2014 and 2019

·       An in-depth analysis of the various patentsthat have been filed / granted related to continuous manufacturing till 2019

·       Initiatives taken by the leadingpharmaceutical companies (in terms of revenues), covering both partnered aswell as in-house projects.

·       A review of the companies offering modularfacilities / modular cleanrooms

·       A case study of the companies offeringtechnologies / equipment

·       A case study on the roadmap for the adoptionof continuous manufacturing technique

Get DetailedPDF Sample: https://www.rootsanalysis.com/reports/308/request-sample.html     

Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)

Purposeof Manufacturing

·       In-House

·       Contract service

Scaleof Operation

·       Commercial

·       Preclinical / Clinical

Typeof Continuous Manufacturing Related Service

·       API Manufacturing

·       End Product manufacturing

Typeof Drug Molecule

·       Biologic

·       Small Molecule

Typeof dosage form

·       Solid

·       Liquid

KeyGeographical Regions

·       North America

·       Europe

·       Asia Pacific

Transcriptsof interviews held with the following senior level representatives ofstakeholder companies

·       Andrea Adamo, Founder and Chief ExecutiveOfficer, Zaiput Flow technologies

·       Bayan Takizawa, Co-Founder and Chief BusinessOfficer, CONTINUUS Pharmaceuticals

·       Nick Thomson, Senior Director ChemicalResearch and Development, Pfizer

·       Himanshu Gadgil, Director and Chief ScientificOfficer, Enzene Biosciences

·       Eric Fang, Chief Scientific Officer,Snapdragon Chemistry)

·       Ian Houson, Technical Project Manager,Continuous Manufacturing and Crystallization, University of Strathclyde

Keycompanies covered in the report

·       AbbVie Contract Manufacturing

·       Ajinomoto Bio-Pharma Services

·       Almac

·       Boehringer Ingelheim BioXcellence

·       Cambrex

·       CordonPharma

·       Hovione

·       Kaneka

·       Lonza

·       Patheon

·       SK biotek

·       WuXi AppTec

Requestfor Customization:

https://www.rootsanalysis.com/reports/308/request-customization.html    

AboutRoots Analysis

RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

ContactInformation

RootsAnalysis Private Limited

GauravChaudhary

+1(415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

 

 

 

AlsoVisit Our Latest Publication:

CellTherapy Manufacturing Market Size, 2030

BiologicsFill / Finish Services Market Size, 2030

VaccineContract Manufacturing Market Size, 2030

mRNATherapeutics and Vaccines Market Size, 2030

ViralVectors, Non-Viral Vectors and Gene Therapy Manufacturing Market

Facebook Conversations